Testing effectiveness (Phase 2)WithdrawnNCT05284604What this trial is testingMesenchymal Stem Cells for Age-Related FrailtyWho this might be right forFrailty VA Office of Research and Development
Not applicableStudy completedNCT00592826What this trial is testingHMP (Home Macular Perimeter) -Usability TrialWho this might be right forAge Related Macular Degeneration Notal Vision Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT00467935What this trial is testingScotoma Reduction in AMD Patients Treated With RanibizumabWho this might be right forMacular Degeneration Retina Research Foundation 20
Early research (Phase 1)Study completedNCT03316521What this trial is testingFirst-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male VolunteersWho this might be right forComplement Mediated Diseases Amyndas Pharmaceuticals S.A. 50
Not applicableStudy completedNCT03076697What this trial is testingSmartphone Screening for Eye DiseasesWho this might be right forDiabetes MellitusGlaucomaAge Related Macular Degeneration+3 more University of Michigan 472
Not applicableLooking for participantsNCT07446582What this trial is testingReal-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker DetectionWho this might be right forAge-Related (Dry) Macular Degeneration AI-Spectral 1,000
Post-approval studies (Phase 4)Study completedNCT02689518What this trial is testingEAGLE: Evaluating Genotypes Using Intravitreal Aflibercept InjectionWho this might be right forMacular DegenerationWet Macular Degeneration University of California, San Diego 50
Not applicableStudy completedNCT03728660What this trial is testingDesign and Clinical Evaluation of a Smartphone-based Low Vision Enhancement SystemWho this might be right forLow Vision Johns Hopkins University 88
Not applicableStudy completedNCT00029120What this trial is testingEvaluation of Age- and Alzheimer's Disease-Related Memory DisorderWho this might be right forAlzheimer DiseaseDementiaMemory Disorder+1 more National Institute of Mental Health (NIMH) 450
Not applicableStudy completedNCT03516110What this trial is testingHealth Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist TherapyWho this might be right forProstate Cancer Ipsen 831
Large-scale testing (Phase 3)Ended earlyNCT00890097What this trial is testingGeographic Atrophy Treatment EvaluationWho this might be right forGeographic AtrophyAge-Related Macular Degeneration Alcon Research 772
Testing effectiveness (Phase 2)Study completedNCT03038880What this trial is testingStudy to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular DegenerationWho this might be right forNeovascularization, ChoroidalMacular Degeneration, Age-Related Hoffmann-La Roche 76
Testing effectiveness (Phase 2)Study completedNCT03953079What this trial is testingA Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMDWho this might be right forNeovascular Age-Related Macular Degeneration Graybug Vision 56
Not applicableLooking for participantsNCT07338461What this trial is testingHigh Resolution Imaging OCT StudyWho this might be right forNormal EyesAge Related Macular DegenerationDiabetic Retinopathy+1 more Heidelberg Engineering GmbH 97
Not applicableStudy completedNCT04265742What this trial is testingMicrobiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone MicroarchitectureWho this might be right forBone Loss, Age-related Institut National de la Santé Et de la Recherche Médicale, France 440
Large-scale testing (Phase 3)Study completedNCT00429962What this trial is testingStudy Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNVWho this might be right forChoroidal NeovascularizationAge-Related Macular Degeneration University Hospital, Basel, Switzerland 40
Not applicableStudy completedNCT01880788What this trial is testingGenetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMDWho this might be right forAge Related Macular DegenerationChoroidal NeovascularizationCentral Serous Chorioretinopathy Sequenom, Inc. 152
Testing effectiveness (Phase 2)Study completedNCT01914159What this trial is testingRanibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration StudyWho this might be right forAge Related Macular Degeneration University Hospital, Bonn 24
Not applicableStudy completedNCT00656903What this trial is testingHigh Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular DegenerationWho this might be right forMacular Degeneration National Eye Institute (NEI) 75
Large-scale testing (Phase 3)Study completedNCT04516278What this trial is testingA 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal DisordersWho this might be right forAge-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more Outlook Therapeutics, Inc. 197